<DOC>
	<DOCNO>NCT02718118</DOCNO>
	<brief_summary>This study design evaluate safety , efficacy , subject investigator satisfaction 2 different injection volume Dysport glabellar line . 1 . To determine proportion composite responder ( base blind evaluator subject assessment ) achieve least 1-point reduction baseline glabellar line severity score ( GLSS ) maximum frown line Day 30 . 2 . To assess GLSS , maximum frown rest , live assessment visit . 3 . To evaluate onset effect appearance glabellar line start Day 2 visit ( subject blind evaluator ) . 4 . To assess subject 's satisfaction treatment . 5 . To evaluate investigator satisfaction treatment outcome . 6 . To evaluate subject psychological well-being . 7 . To evaluate subject age appraisal . 8 . To evaluate adverse event course study .</brief_summary>
	<brief_title>Comparison Dysport Reconstitution 1.5 mL 2.5 mL Treatment Moderate Severe Glabellar Lines</brief_title>
	<detailed_description>Five month , randomize , subject- evaluator-blinded , multi-center , mult-visit study . Subjects treat Dysport follow US on-label guideline .</detailed_description>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Key 1 . Botulinum toxin naïve subject ( facial area ) 2 . Moderate severe ( GLSS = 2 3 ) glabellar line maximum frown mild severe ( GLSS = 1 , 2 , 3 ) glabellar line rest use validate 4point Photographic Scale , assess treat investigator blind evaluator . Key 1 . Have know allergy sensitivity Dysport® , excipients , cow 's milk protein 2 . Have rhytids glabellar region smooth manually spread skin apart 3 . Have history sign symptom eyelid brow ptosis sign compensatory frontalis muscle activity , judge investigator 4 . Have clinical subclinical neuromuscular junctional disorder ( eg , myasthenia gravis , Lambert Eaton syndrome , amyotrophic lateral sclerosis ) history dysphagia aspiration 5 . Are woman pregnant breastfeed intend get pregnant within duration study 6 . Have active inflammation infection area treat prior surgery , tattoo , piercings , scar facial area , opinion investigator , may interfere result 7 . Have previous insertion permanent semipermanent material , hyaluronic acid , collagen filler glabellar region 8 . Have chronic acute medical condition , may pose risk safety subject , may interfere assessment safety efficacy study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>